Abstract
The study reports the results of treatment in 31 infants under age 12 months with stage IV-S neuroblastoma diagnosed between 1976 and 1979. All had small or undetected primary tumours associated with disease in one or more of the following sites: liver, skin, or marrow. The primary site was left adrenal (in 16), and other areas included paravertebral, mediastinum, and pelvis (in 5); in 3 the primary site could not be found. Distant disease was found in the liver (in 29), marrow (in 16), and skin (in 8). Other sites affected were pancreas, pleura, peritoneum, and regional nodes. Treatment varied according to the clinical course of the disease; most patients had very little. In 19 primary tumour was resected, in 21 the liver was irradiated with a median dose of 450 rad, and 15 received chemotherapy in courses varying between 1 month and 1 year. Nine patients had resection of the primary tumour as their only treatment and all survive; a total of 16 patients had sites of disease which regressed spontaneously. Four of 31 patients died in the first 2 months despite vigorous measures, all from some complication of the disease or its treatment. The projected 2-year survival rate is 87%. Children with this 'special' pattern of widespread neuroblastoma fare well with little or no treatment unless early complications develop. In this study none died of late progression of their disease.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bansal N., Wainstein M., Kropp K. A. Congenital hydronephrosis with ipsilateral adrenal neuroblastoma: a case report. J Urol. 1978 Sep;120(3):354–355. doi: 10.1016/s0022-5347(17)57172-4. [DOI] [PubMed] [Google Scholar]
- Bond J. V. Neuroblastoma metastatic to the liver in infants. Arch Dis Child. 1976 Nov;51(11):879–882. doi: 10.1136/adc.51.11.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breslow N., McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res. 1971 Dec;31(12):2098–2103. [PubMed] [Google Scholar]
- D'Angio G. J., Evans A. E., Koop C. E. Special pattern of widespread neuroblastoma with a favourable prognosis. Lancet. 1971 May 22;1(7708):1046–1049. doi: 10.1016/s0140-6736(71)91606-0. [DOI] [PubMed] [Google Scholar]
- Evans A. E., Chatten J., D'Angio G. J., Gerson J. M., Robinson J., Schnaufer L. A review of 17 IV-S neuroblastoma patients at the children's hospital of philadelphia. Cancer. 1980 Mar 1;45(5):833–839. doi: 10.1002/1097-0142(19800301)45:5<833::aid-cncr2820450502>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- Evans A. E., D'Angio G. J., Randolph J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer. 1971 Feb;27(2):374–378. doi: 10.1002/1097-0142(197102)27:2<374::aid-cncr2820270221>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Evans A. E., Hummeler K. The significance of primitive cells in marrow aspirates of children with neuroblastoma. Cancer. 1973 Oct;32(4):906–912. doi: 10.1002/1097-0142(197310)32:4<906::aid-cncr2820320423>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
- Hartmann J. R. Chemotherapy of metastatic neuroblastoma. J Pediatr Surg. 1968 Feb;3(1):181–182. doi: 10.1016/0022-3468(68)91012-9. [DOI] [PubMed] [Google Scholar]
- Schnaufer L., Koop C. E. Silastic abdominal patch for temporary hepatomegaly in Stage IV-S neuroblastoma. J Pediatr Surg. 1975 Feb;10(1):73–75. doi: 10.1016/s0022-3468(75)80012-1. [DOI] [PubMed] [Google Scholar]